Literature DB >> 7527826

Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense.

D P Speert1, M Bond, R C Woodman, J T Curnutte.   

Abstract

Pseudomonas aeruginosa and Pseudomonas cepacia are catalase-producing bacteria, but only P. cepacia causes infections in patients with chronic granulomatous disease (CGD). The in vitro killing of P. aeruginosa and P. cepacia by polymorphonuclear leukocytes (PMNL) from patients with CGD and from healthy adults was assessed. Of 6 patients with CGD who developed severe infections with P. cepacia, 4 died. PMNL from the 2 survivors and 6 other patients with CGD killed P. aeruginosa strains efficiently and P. cepacia strains poorly. PMNL from 2 patients with autosomal recessive CGD and from 2 carriers for X-linked CGD killed P. cepacia intermediately between normal controls and patients with X-linked CGD. When superoxide anion and hydrogen peroxide were scavenged with superoxide dismutase and catalase, normal PMNL killed P. aeruginosa but not P. cepacia. Thus, P. cepacia, but not P. aeruginosa, is a pathogen in patients with CGD, because it resists neutrophil-mediated nonoxidative bactericidal effects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527826     DOI: 10.1093/infdis/170.6.1524

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  51 in total

1.  Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.

Authors:  E Mahenthiralingam; T Coenye; J W Chung; D P Speert; J R Govan; P Taylor; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

3.  Molecular typing of, and distribution of genetic markers among, Burkholderia cepacia complex isolates from Brazil.

Authors:  Maria G Detsika; John E Corkill; Marcelo Magalhães; Kerry J Glendinning; C Anthony Hart; Craig Winstanley
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

4.  Virulence properties of Pseudomonas aeruginosa lacking the extreme-stress sigma factor AlgU (sigmaE).

Authors:  H Yu; J C Boucher; N S Hibler; V Deretic
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 5.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

6.  Identification of hopanoid biosynthesis genes involved in polymyxin resistance in Burkholderia multivorans.

Authors:  Rebecca J Malott; Barbara R Steen-Kinnaird; Tracy D Lee; David P Speert
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

7.  Redundant contribution of myeloperoxidase-dependent systems to neutrophil-mediated killing of Escherichia coli.

Authors:  H Rosen; B R Michel
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

8.  Burkholderia pseudomallei infection in chronic granulomatous disease.

Authors:  Raffaele Renella; Jean-Marie Perez; Sylvie Chollet-Martin; Sabine Sarnacki; Alain Fischer; Stéphane Blanche; Jean-Laurent Casanova; Capucine Picard
Journal:  Eur J Pediatr       Date:  2005-12-03       Impact factor: 3.183

9.  Cloning and characterization of the katB gene of Pseudomonas aeruginosa encoding a hydrogen peroxide-inducible catalase: purification of KatB, cellular localization, and demonstration that it is essential for optimal resistance to hydrogen peroxide.

Authors:  S M Brown; M L Howell; M L Vasil; A J Anderson; D J Hassett
Journal:  J Bacteriol       Date:  1995-11       Impact factor: 3.490

10.  Energy-generating enzymes of Burkholderia cepacia and their interactions with macrophages.

Authors:  Vasu Punj; Rachna Sharma; Olga Zaborina; A M Chakrabarty
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.